$178,71
-$1,29(-0,71%)
*Data last updated: 2026-05-10 17:16 (UTC+8)
As of 2026-05-10 17:16, IQVIA Holdings Inc (IQV) is priced at $178,71, with a total market cap of $29,82B, a P/E ratio of 28,49, and a dividend yield of 0,00%. Today, the stock price fluctuated between $175,01 and $183,74. The current price is 2,11% above the day's low and 2,73% below the day's high, with a trading volume of 835,47K. Over the past 52 weeks, IQV has traded between $146,50 to $183,74, and the current price is -2,73% away from the 52-week high.
IQV Key Stats
Yesterday's Close$178,64
Market Cap$29,82B
Volume835,47K
P/E Ratio28,49
Dividend Yield (TTM)0,00%
Diluted EPS (TTM)8,22
Net Income (FY)$1,36B
Revenue (FY)$16,31B
Earnings Date2026-07-28
EPS Estimate3,03
Revenue Estimate$4,30B
Shares Outstanding166,96M
Beta (1Y)1.179
About IQV
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
SectorHealthcare
IndustryMedical - Diagnostics & Research
CEOAri Bousbib
HeadquartersDurham,NC,US
Official Websitehttps://www.iqvia.com
Employees (FY)93,00K
Average Revenue (1Y)$175,37K
Net Income per Employee$14,62K
IQVIA Holdings Inc (IQV) FAQ
What's the stock price of IQVIA Holdings Inc (IQV) today?
x
IQVIA Holdings Inc (IQV) is currently trading at $178,71, with a 24h change of -0,71%. The 52-week trading range is $146,50–$183,74.
What are the 52-week high and low prices for IQVIA Holdings Inc (IQV)?
x
What is the price-to-earnings (P/E) ratio of IQVIA Holdings Inc (IQV)? What does it indicate?
x
What is the market cap of IQVIA Holdings Inc (IQV)?
x
What is the most recent quarterly earnings per share (EPS) for IQVIA Holdings Inc (IQV)?
x
Should you buy or sell IQVIA Holdings Inc (IQV) now?
x
What factors can affect the stock price of IQVIA Holdings Inc (IQV)?
x
How to buy IQVIA Holdings Inc (IQV) stock?
x
Risk Warning
The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.
Disclaimer
The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.
